Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 101–200 of 1,007
The Influence of Metabolism on Drug Response in Cancer
Zaal, E. A., & Berkers, C. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00500 · Cited by 272
“However, cancer cells also prefer glycolysis when mitochondrial function is intact (49, 50), suggesting that glycolysis confers other advantages to cancer cells.”
BackgroundMechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
Adeshakin, F. O., Adeshakin, A. O., Afolabi, L. O., Yan, D., Zhang, G., & Wan, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626577 · Cited by 271
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment
Yu, W., Lei, Q., Yang, L., Qin, G., Liu, S., Wang, D., Ping, Y., & Zhang, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01200-4 · Cited by 266
“Anti‐tumor effects of lipids in tumor immune response Nutrient limitation caused by an insufficient vascular exchange in the TME can result in intense competition between immune cells and rapidly proliferating cancer cells, which modifies anti-tumor immune defense [45].”
BackgroundRole of tumor and host autophagy in cancer metabolism
Poillet-Perez, L., & White, E. (2019) · Genes & Development · doi:10.1101/gad.325514.119 · Cited by 266
“Tumors obtain their entire nutrient supply from the host to fuel these pathways (DeBerardinis and Chandel 2016; Pavlova and Thompson 2016; Vander Heiden and DeBerardinis 2017).”
BackgroundDong, S., Dong, Y., Zhao, Z., Liu, J., Liu, S., Feng, L., He, F., Gai, S., Xie, Y., & Yang, P. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09608 · Cited by 267
Song, X., Liu, J., Kuang, F., Chen, X., Zeh, H. J., Kang, R., Kroemer, G., Xie, Y., & Tang, D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108767 · Cited by 260
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Li, Y., Liu, F., Cai, Q., Deng, L., Ouyang, Q., Zhang, X. H.-F., & Zheng, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02148-4 · Cited by 244
“222,223 Some tumors demonstrate a proclivity for anaerobic glycolysis, whereas others rely on oxidative phosphorylation (OXPHOS) for energy production.”
The ins and outs of serine and glycine metabolism in cancer
Geeraerts, S. L., Heylen, E., De Keersmaecker, K., & Kampen, K. R. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00329-9 · Cited by 247
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Hoppenz, P., Els-Heindl, S., & Beck-Sickinger, A. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00571 · Cited by 242
“, 2015), altered epigenetic regulation mechanisms (Pfister and Ashworth, 2017), the overproduction of enzymes (DeBerardinis and Chandel, 2016) or changes in the cellular microenvironment such as a lower pH (Kato et al.”
BackgroundResveratrol: An overview of its anti-cancer mechanisms
Elshaer, M., Chen, Y., Wang, X. J., & Tang, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.028 · Cited by 245
“Moreover, a substantial fraction of glucose carbon, in the form of assorted glycolytic intermediates, is shunted into multiple biosynthetic pathways instead of giving rise to pyruvate [114].”
BackgroundMitochondrial sirtuins, metabolism, and aging
Ji, Z., Liu, G.-H., & Qu, J. (2022) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.11.005 · Cited by 242
Metabolic reprogramming in triple-negative breast cancer
Sun, X., Wang, M., Wang, M., Yu, X., Guo, J., Sun, T., Li, X., Yao, L., Dong, H., & Xu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00428 · Cited by 243
Multifaceted role of branched-chain amino acid metabolism in cancer
Peng, H., Wang, Y., & Luo, W. (2020) · Oncogene · doi:10.1038/s41388-020-01480-z · Cited by 240
“Distinct to normal non-proliferating cells, the malignant properties of cancer cells, including rapid proliferation and aggressive invasion into normal tissues, require altered metabolism to meet increased nutritional and biosynthetic demands [1, 2].”
BackgroundDNA Damage, Repair, and Cancer Metabolism
Turgeon, M.-O., Perry, N. J. S., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00015 · Cited by 241
“Cold Spring Harb Perspect Biol (2013) 5(9):a012716.”
BackgroundMachine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma
Huang, L., Wang, L., Hu, X., Chen, S., Tao, Y., Su, H., Yang, J., Xu, W., Vedarethinam, V., Wu, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17347-6 · Cited by 240
Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Gandhi, N., & Das, G. (2019) · Cells · doi:10.3390/cells8020089 · Cited by 227
“While the importance of glycolysis in the survival and progression of certain cancers is undeniable, it has increasingly become evident that cancer cells may preferentially utilize a number of alternative metabolic pathways to drive their phenotype [2,3].”
BackgroundSerine, glycine and one‑carbon metabolism in cancer (Review)
Pan, S., Fan, M., Liu, Z., Li, X., & Wang, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5158 · Cited by 227
Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
Li, F., & Simon, M. C. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.018 · Cited by 221
“Nutrient Competition between Cancer Cells and Immune Cells To maximize nutrient utilization, cancer cells must compete with stromal cells for limited substrates, especially under metabolic stress (De Berardinis and Chandel, 2016; Nakazawa et al., 2016; Pavlova and Thompson, 2016).”
BackgroundMetabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
Ohshima, K., & Morii, E. (2021) · Metabolites · doi:10.3390/metabo11010028 · Cited by 220
“Moreover, mitochondrial respiration and function are also required for tumor growth, although the Warburg effect is often misinterpreted as an indication that the mitochondrial oxidative metabolism is defective [3,14].”
BackgroundGanapathy-Kanniappan, S. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1556578 · Cited by 216
“…Warburg’s original hypothesis that lack of mitochondrial capacity underlies aerobic glycolysis, multiple lines of evidence from modern research unequivocally establish that tumor glycolysis is not necessarily a consequence of impaired or dysfunctional mitochondria (DeBerardinis and Chandel 2016).”
BackgroundMolecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism
Somasundaram, V., Basudhar, D., Bharadwaj, G., No, J. H., Ridnour, L. A., Cheng, R. Y. S., Fujita, M., Thomas, D. D., Anderson, S. K., McVicar, D. W., et al. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7527 · Cited by 213
“P53 reduces glucose uptake by inhibiting GLUT expression, and increases glutamine fueling of TCA by upregulating glutaminase (GLS) that converts glutamine to glutamate that then feeds into the TCA through a-KG (32, 36, 92).”
BackgroundInfluentialCancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 214
“…metabolic plasticity to exploit other resources originating from their microenvironment, such as glutamine, lipids, various amino acids and even nearby host and cancer cells that can be engulfed to generate metabolic intermediates and precursors in the process of cellular cannibalism [66 – 68].”
Metabolic reprogramming in prostate cancer
Ahmad, F., Cherukuri, M. K., & Choyke, P. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01435-5 · Cited by 212
“This alteration is, in part, orchestrated by the genetic changes that govern tumorigenesis,(2) such as the activation of oncogenes and/or the loss of tumour suppressor genes, and is further shaped by environmental factors, such as nutrient availability and oxygen concentration.(9) Tumours predominantly exhibit heterog…”
BackgroundSingle-cell and spatial transcriptomics analysis of non-small cell lung cancer
De Zuani, M., Xue, H., Park, J. S., Dentro, S. C., Seferbekova, Z., Tessier, J., Curras-Alonso, S., Hadjipanayis, A., Athanasiadis, E. I., Gerstung, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48700-8 · Cited by 209
“While the importance of glycolysis in tumour cells is well-established 39 , it was recently reported that human NSCLC use glucose and lactate to fuel the tricarboxylic acid (TCA) cycle 40 .”
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
Chen, P.-H., Cai, L., Huffman, K., Yang, C., Kim, J., Faubert, B., Boroughs, L., Ko, B., Sudderth, J., McMillan, E. A., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.028 · Cited by 212
Self-citationMacrophage function in obesity-induced inflammation and insulin resistance
Lauterbach, M. A. R., & Wunderlich, F. T. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1955-5 · Cited by 212
“OXPHOS is the most effective way for cells to generate ATP and is used by most quiescent cell types to cover their energetic demands [15].”
BackgroundCytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting
Alkan, H. F., Walter, K. E., Luengo, A., Madreiter-Sokolowski, C. T., Stryeck, S., Lau, A. N., Al-Zoughbi, W., Lewis, C. A., Thomas, C. J., Hoefler, G., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.021 · Cited by 209
“Despite prominent lactate production, mitochondrial function remains important for proliferating cells (DeBerardinis and Chandel, 2016).”
Ghanbari Movahed, Z., Rastegari-Pouyani, M., Mohammadi, M. H., & Mansouri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108690 · Cited by 208
Geffen, Y., Anand, S., Akiyama, Y., Yaron, T. M., Song, Y., Johnson, J. L., Govindan, A., Babur, Ö., Li, Y., Huntsman, E., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.013 · Cited by 209
“In these pathways, acetylation is known to play an important inhibitory role.(7,76,77) We observed high levels of acetylation in lipid metabolism pathways in the immune-hot group and low levels of acetylation in the immune-cool subtype (FDR < 0.”
Metabolic reprogramming in renal cancer: Events of a metabolic disease
Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 204
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer
Sonkar, K., Ayyappan, V., Tressler, C. M., Adelaja, O., Cai, R., Cheng, M., & Glunde, K. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4112 · Cited by 205
Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
Wang, S., Fu, J.-L., Hao, H.-F., Jiao, Y.-N., Li, P.-P., & Han, S.-Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105728 · Cited by 200
SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
Lee, J., & Roh, J.-L. (2022) · Antioxidants · doi:10.3390/antiox11122444 · Cited by 199
“Altered energy metabolism is a hallmark of cancer that can be an effective treatment target [72].”
BackgroundCutshaw, G., Uthaman, S., Hassan, N., Kothadiya, S., Wen, X., & Bardhan, R. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00897 · Cited by 199
Dietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 201
Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis
Diebold, L. P., Gil, H. J., Gao, P., Martinez, C. A., Weinberg, S. E., & Chandel, N. S. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0011-x · Cited by 201
Self-citationYang, J., Griffin, A., Qiang, Z., & Ren, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01243-0 · Cited by 196
“Go in for the kill: how to trigger unfolded protein response? In comparison to normal cells, cancer cells reprogram their intrinsic metabolism patterns to adapt unfavorable environments for survival and then relentlessly proliferate.(340) A wide variety of studies have indicated that ER stress and UPR activity are dir…”
BackgroundGoetzman, E. S., & Prochownik, E. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00129 · Cited by 199
“, prostate cancer) most cancers are glucose/glutamine dependent and not FAO dependent (277, 278).”
BackgroundTargeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
Kouidhi, S., Ben Ayed, F., & Benammar Elgaaied, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00353 · Cited by 196
“org February 2018 | Volume 9 | Article 353 Furthermore, glycolysis is an effective metabolic pathway for highly proliferative cancer cells to supply nucleotide, lipid, and amino acid synthesis (45).”
BackgroundDysregulation of glutaminase and glutamine synthetase in cancer
Matés, J. M., Campos-Sandoval, J. A., Santos-Jiménez, J. D. L., & Márquez, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.011 · Cited by 196
Fischer, G. M., Vashisht Gopal, Y. N., McQuade, J. L., Peng, W., DeBerardinis, R. J., & Davies, M. A. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12661 · Cited by 193
“However, the role of one- carbon metabolism, mediated by the folate cofactor, becomes increasingly important as tumorigenesis progresses, glucose becomes scarce, and hypoxia becomes a more significant source of ROS (DeBerardinis & Chandel, 2016).”
InfluentialSelf-citationTargeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells
Wang, X., Yang, K., Wu, Q., Kim, L. J. Y., Morton, A. R., Gimple, R. C., Prager, B. C., Shi, Y., Zhou, W., Bhargava, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau4972 · Cited by 193
“Genetic mutations and metabolic alterations interact bidirectionally (9, 10).”
BackgroundCombining discovery and targeted proteomics reveals a prognostic signature in oral cancer
Carnielli, C. M., Macedo, C. C. S., De Rossi, T., Granato, D. C., Rivera, C., Domingues, R. R., Pauletti, B. A., Yokoo, S., Heberle, H., Busso-Lopes, A. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05696-2 · Cited by 194
Metabolism and Colorectal Cancer
Sedlak, J. C., Yilmaz, Ö. H., & Roper, J. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-041113 · Cited by 191
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Xue, D., Zhou, X., & Qiu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110676 · Cited by 191
Liu, W., Zhang, X., Xu, H., Li, S., Lau, H. C.-H., Chen, Q., Zhang, B., Zhao, L., Chen, H., Sung, J. J.-Y., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.020 · Cited by 188
Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis
Bonnay, F., Veloso, A., Steinmann, V., Köcher, T., Abdusselamoglu, M. D., Bajaj, S., Rivelles, E., Landskron, L., Esterbauer, H., Zinzen, R. P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.039 · Cited by 188
Takahashi, N., Cho, P., Selfors, L. M., Kuiken, H. J., Kaul, R., Fujiwara, T., Harris, I. S., Zhang, T., Gygi, S. P., & Brugge, J. S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.010 · Cited by 189
“However, this causes the production of toxic metabolic byproducts, including reactive oxygen species (ROS), that can promote oxidative stress and impair cancer cell viability (DeBerardinis and Chandel, 2016; Gorrini et al., 2013; Schafer et al., 2009; Tennant et al., 2010).”
BackgroundInterfering with Tumor Hypoxia for Radiotherapy Optimization
Telarovic, I., Wenger, R. H., & Pruschy, M. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02000-x · Cited by 185
Roles of Aldolase Family Genes in Human Cancers and Diseases
Chang, Y.-C., Yang, Y.-C., Tien, C.-P., Yang, C.-J., & Hsiao, M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.05.003 · Cited by 186
Mitochondrial ribosomes in cancer
Kim, H.-J., Maiti, P., & Barrientos, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.004 · Cited by 184
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Sun, D., Li, X., Nie, S., Liu, J., & Wang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113993 · Cited by 182
A Tale of Two Glutaminases: Homologous Enzymes with Distinct Roles in Tumorigenesis
Katt, W. P., Lukey, M. J., & Cerione, R. A. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0190 · Cited by 181
Metabolic Plasticity in Chemotherapy Resistance
Desbats, M. A., Giacomini, I., Prayer-Galetti, T., & Montopoli, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00281 · Cited by 183
“In the last decades, several studies have demonstrated that metabolic reprogramming plays an important role in the onset of chemotherapy resistance (106).”
BackgroundThe folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation
Shang, M., Yang, H., Yang, R., Chen, T., Fu, Y., Li, Y., Fang, X., Zhang, K., Zhang, J., Li, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22173-5 · Cited by 179
Houghton, C. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2716870 · Cited by 179
“However, the use of a phytochemical in chemoprevention engages very different biochemical processes when using the same molecule in chemotherapy; the biochemical behaviour of cancer cells and normal cells is very different [240].”
BackgroundMetabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
Moldogazieva, N. T., Mokhosoev, I. M., & Terentiev, A. A. (2020) · Cancers · doi:10.3390/cancers12040862 · Cited by 177
Redox Potential of Antioxidants in Cancer Progression and Prevention
George, S., & Abrahamse, H. (2020) · Antioxidants · doi:10.3390/antiox9111156 · Cited by 178
Applications of metabolomics to study cancer metabolism
Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179
“tumor suppressors), the tumor microenvironment (which imposes metabolic stress caused by compromised nutrients and oxygen availability), and other influences[1-3].”
Self-citationFatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets
Tan, S. K., Hougen, H. Y., Merchan, J. R., Gonzalgo, M. L., & Welford, S. M. (2023) · Nature Reviews Urology · doi:10.1038/s41585-022-00654-6 · Cited by 179
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Chalishazar, M. D., Wait, S. J., Huang, F., Ireland, A. S., Mukhopadhyay, A., Lee, Y., Schuman, S. S., Guthrie, M. R., Berrett, K. C., Vahrenkamp, J. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4140 · Cited by 174
“Metabolic changes accompanying cell transformation are necessary to meet the metabolic demands of malignant cells, which include changes in energy formation, biosynthesis and redox homeostasis (21).”
BackgroundSelf-citationMetabolic reprogramming in cholangiocarcinoma
Raggi, C., Taddei, M. L., Rae, C., Braconi, C., & Marra, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.038 · Cited by 176
Connections between metabolism and epigenetics in cancers
Thakur, C., & Chen, F. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.006 · Cited by 174
Moldogazieva, N. T., Lutsenko, S. V., & Terentiev, A. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0980 · Cited by 173
Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
Gregory, M. A., Nemkov, T., Park, H. J., Zaberezhnyy, V., Gehrke, S., Adane, B., Jordan, C. T., Hansen, K. C., D’Alessandro, A., & DeGregori, J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3223 · Cited by 171
A landscape of metabolic variation across tumor types
Reznik, E., Luna, A., Aksoy, B. A., Liu, E. M., La, K., Ostrovnaya, I., Creighton, C. J., Hakimi, A. A., & Sander, C. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.014 · Cited by 172
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, E. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 170
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
Chiaradonna, F., Ricciardiello, F., & Palorini, R. (2018) · Cells · doi:10.3390/cells7060053 · Cited by 168
“On the other hand, the pyruvate produced by glycolysis is converted to lactate, and this step is essential for the regeneration of NAD+ in the cytosol to sustain the high glycolytic rate observed in tumors [2,3].”
BackgroundInfluentialBader, D. A., Hartig, S. M., Putluri, V., Foley, C., Hamilton, M. P., Smith, E. A., Saha, P. K., Panigrahi, A., Walker, C., Zong, L., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0002-y · Cited by 166
“Correction factor was calculated by: (1) median centring across samples of all antibody experiments; and (2) median-centring across antibodies for each sample.”
EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells
(2020) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.04.003 · Cited by 161
Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
Anwar, S., Shamsi, A., Mohammad, T., Islam, A., & Hassan, M. I. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188568 · Cited by 161
Nerve-to-cancer transfer of mitochondria during cancer metastasis
Hoover, G., Gilbert, S., Curley, O., Obellianne, C., Lin, M. T., Hixson, W., Pierce, T. W., Andrews, J., ALEXEYEV, M. F., Ding, Y., et al. (2025) · Nature · doi:10.1038/s41586-025-09176-8 · Cited by 195
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
Kreuzaler, P., Panina, Y., Segal, J., & Yuneva, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.021 · Cited by 163
“Published A consequence of the high metabolic activity and unstable blood supply in tumors is an increased production of reactive oxygen species (ROS) such as O2 , H2O2, and OH , mainly due to electron leakage from ETC as well as the NADPH oxidases (NOXs) [148,149].”
BackgroundInfluentialStarvation, Stress Resistance, and Cancer
Buono, R., & Longo, V. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.008 · Cited by 162
Targeting Metabolic–Redox Circuits for Cancer Therapy
Wang, K., Jiang, J., Lei, Y., Zhou, S., Wei, Y., & Huang, C. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.001 · Cited by 162
Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer
Matés, J. M., Di Paola, F. J., Campos-Sandoval, J. A., Mazurek, S., & Márquez, J. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.012 · Cited by 162
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
De Matteis, S., Ragusa, A., Marisi, G., De Domenico, S., Casadei Gardini, A., Bonafè, M., & Giudetti, A. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7512159 · Cited by 160
“The common feature of these alterations is an increased glucose uptake and production of lactate even in the presence of oxygen and fully functioning mitochondria (Warburg effect) [2, 3], but it is not correlated with enhanced gluconeogenesis as the expression of phosphoenolpyruvate carboxykinases 1 and 2 and fructose…”
BackgroundTargeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. A. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159
“This reflects a phenomenon termed ‘metabolic flexibility’ where cancer cells adjust their metabolic phenotypes in order to gain a selective advantage for cell growth and survival under hostile conditions throughout tumorigenesis up to the time of metastasis [7].”
BackgroundGao, T., Zhang, X., Zhao, J., Zhou, F., Wang, Y., Zhao, Z., Xing, J., Chen, B., Li, J., & Liu, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.029 · Cited by 164
Lee, S., & Griffiths, J. R. (2020) · Cancers · doi:10.3390/cancers12061616 · Cited by 179
“Numerous studies on cancer metabolism over the past decade have revealed that cancer cells exhibit aerobic glycolysis due to the activation of oncogenes, the loss of tumour suppressor genes, and the upregulation of the PI3K pathway, and that one advantage of these high glycolytic rates is the availability of precursor…”
BackgroundHazrati, A., Soudi, S., Malekpour, K., Mahmoudi, M., Rahimi, A., Hashemi, S. M., & Varma, R. S. (2022) · Biomarker Research · doi:10.1186/s40364-022-00374-4 · Cited by 171
“via HISLA transfer [91]; HIF-1α is an oxygen-sensing transcription factor that determines the type of glucose consumption by oxidation or glycolysis [92].”
Siddiqui, F. A., Prakasam, G., Chattopadhyay, S., Rehman, A. U., Padder, R. A., Ansari, M. A., Irshad, R., Mangalhara, K. C., Bamezai, R. N. K., Husain, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25524-3 · Cited by 173
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Biancur, D. E., & Kimmelman, A. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.011 · Cited by 152
“Glucose: Glucose fuels cancer cell proliferation by providing carbon for anabolic reactions that generate biosynthetic intermediates and through the production of ATP (fermentation or oxidation of pyruvate) [49].”
BackgroundTumour metabolism and its unique properties in prostate adenocarcinoma
Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 181
Wu, S., Wang, H., Li, Y., Xie, Y., Huang, C., Zhao, H., Miyagishi, M., & Kasim, V. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-4047 · Cited by 163
“Excessive oxidative stress is hazardous as it could damage cellular components including DNA, proteins, and lipids (3,36,37), eventually initiating cell death signaling pathways; while NADPH provides the reducing power for both the glutathione and thioredoxin systems, which are crucial for the clearance of ROS produce…”
BackgroundXia, H., Wang, W., Crespo, J., Kryczek, I., Li, W., Wei, S., Bian, Z., Maj, T., He, M., Liu, R. J., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan4631 · Cited by 150
“Many types of tumor metabolically rely on glycolysis to generate adenosine triphosphate, which is followed by lactic acid fermentation and lactate production (44).”
BackgroundVrettos, E. I., Mező, G., & Tzakos, A. G. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.80 · Cited by 176
Mechanisms of resistance to chemotherapy in non-small cell lung cancer
Min, H., & Lee, H. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01312-y · Cited by 178
Chen, W., Jiang, J., Gong, L., Shu, Z., Xiang, D., Zhang, X., Bi, K., & Diao, H. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01803-8 · Cited by 149
“Among the 6 biological pathways, glycolysis/ gluconeogenesis was found to be closely associated with metabolism that drives tumorigenesis [30].”
BackgroundThe metabolic landscape of lung cancer: New insights in a disturbed glucose metabolism
Vanhove, K., Graulus, G.-J., Mesotten, L., Thomeer, M., Derveaux, E., Noben, J.-P., Guedens, W., & Adriaensens, P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01215 · Cited by 147
“Respiration, oxidativemetabolism and othermitochondrial pathways are required by malignant cells for tumor growth (3, 60).”
BackgroundExploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
Wolpaw, A. J., & Dang, C. V. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.006 · Cited by 146
“Specifically, glycolysis is the most conserved pathway that converts glucose to pyruvate (Figure 1), which is further catabolized to lactate, alanine, alcohol, or transported into the mitochondrion depending on the metabolic wiring of the cell [5, 6].”
BackgroundMetabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Jagušt, P., de Luxán‐Delgado, B., Parejo-Alonso, B., & Sancho, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00203 · Cited by 154
Ma, Y., Wang, W., Idowu, M. O., Oh, U., Wang, X.-Y., Temkin, S. M., & Fang, X. (2018) · Cancers · doi:10.3390/cancers11010033 · Cited by 145
“Recent advances in understanding of metabolic transformations have opened new and promising avenues for developing alternative therapies to target cancer cell metabolism for ovarian cancer and other malignant diseases [2].”
BackgroundDirect stimulation of NADP + synthesis through Akt-mediated phosphorylation of NAD kinase
Hoxhaj, G., Ben-Sahra, I., Lockwood, S. E., Timson, R. C., Byles, V., Henning, G. T., Gao, P., Selfors, L. M., Asara, J. M., & Manning, B. D. (2019) · Science · doi:10.1126/science.aau3903 · Cited by 144
Navarro, C., Ortega, Á., Santeliz, R., Garrido, B., Chacín, M., Galbán, N., Vera, I., Sanctis, J. B. D., & Bermúdez, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061303 · Cited by 168
“lipids, and proteins to provide a pro-tumorigenic response in the face of the acquisition and maintenance of malignant properties [5].”
BackgroundImplications of reactive oxygen species on cancer formation and its treatment
Shah, M. A., & Rogoff, H. A. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.05.002 · Cited by 170
KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Pupo, E., Avanzato, D., Middonti, E., Bussolino, F., & Lanzetti, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00848 · Cited by 143
“The major outcome of increased glycolysis is the generation of intermediates that can be used as building blocks by other metabolic routes to synthetize nucleotides, amino acids, and fatty acids which are required by the rapidly dividing cells to generate the tumor mass (20).”
BackgroundBai, W., Shin, J. H., Fu, R., Kandela, I. K., Lu, D., Ni, X., Park, Y., Liu, Z., Hang, T., Wu, D., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0435-y · Cited by 149
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.